Author:
Springer Caroline J.,Niculescu-Duvaz Ion
Reference168 articles.
1. Workman, P. (2000) Editorial overview. Toward genomic cancer pharmacology: innovative drugs for the new millennium. Curr. Opin. Oncol. Endocrine Metab. Investig. Drugs
2, 21–25.
2. Niculescu-Duvaz, I. and Springer, C. J. (1995) Antibody-directed enzyme prodrug therapy (ADEPT): a targeting strategy in cancer chemotherapy. Curr. Med. Chem.
2, 687–706.
3. Melton, R. G. and Knox, R. (1999) Enzyme-Prodrug Strategies for Cancer Therapy. Kluwer Academic/Plenum, New York.
4. Roth, J. A. and Cristiano, R. G. (1997) Gene therapy for cancer: what have we done and where are we going? J. Natl. Cancer Inst.
89, 21–30.
5. Niculescu-Duvaz, I., Spooner, R., Marais, R., and Springer, C. J. (1998) Gene-directed enzyme prodrug therapy. Bioconj. Chem.
9, 4–22.